Hot News NEXT BODY Tattoos
Hot News NEXT BODY Tattoos
Hot News NEXT BODY Tattoos
Showing posts with label Malignant Mesothelioma. Show all posts
Showing posts with label Malignant Mesothelioma. Show all posts

Friday, 12 June 2009

Malignant Mesothelioma

Malignant mesothelioma, a rare form of cancer, is a disease in which cancer (malignant) cells are found in the sac lining the chest (the pleura) or abdomen (the peritoneum). Most people with malignant mesothelioma have worked on jobs where they breathed asbestos.

A doctor should be seen if a person has shortness of breath, pain in the chest, or pain or swelling in the abdomen. If there are symptoms, the doctor may order an x-ray of the chest or abdomen.

The doctor may look inside the chest cavity with a special instrument called a thoracoscope. A cut will be made through the chest wall and the thoracoscope will be put into the chest between two ribs. This test, called thoracoscopy, is usually done in the hospital. Before the test, the patient will be given a local anesthetic (a drug that causes a loss of feeling for a short period of time). Some pressure may be felt, but usually there is no pain.

The doctor may also look inside the abdomen (peritoneoscopy) with a special tool called a peritoneoscope. The peritoneoscope is put into an opening made in the abdomen. This test is also usually done in the hospital. Before the test is done, a local anesthetic will be given.

If tissue that is not normal is found, the doctor will need to cut out a small piece and have it looked at under a microscope to see if there are any cancer cells. This is called a biopsy. Biopsies are usually done during the thoracoscopy or peritoneoscopy.

The chance of recovery (prognosis) depends on the size of the cancer, where the cancer is, how far the cancer has spread, how the cancer cells look under the microscope, how the cancer responds to treatment, and the patient's age.

Malignant Mesothelioma Treatment

There are treatments for all patients with malignant mesothelioma. Three kinds of treatment are used:

Surgery (taking out the cancer)

Radiation Therapy (using high-dose x-rays or other high-energy rays to kill cancer cells)

Chemotherapy (using drugs to fight the cancer)

Surgery is a common treatment of malignant mesothelioma. The doctor may remove part of the lining of the chest or abdomen and some of the tissue around it. Depending on how far the cancer has spread, a lung also may be removed in an operation called a pneumonectomy. Sometimes part of the diaphragm, the muscle below the lungs that helps with breathing, is also removed.

Radiation therapy uses high-energy x-rays to kill cancer cells and shrink tumors. Radiation may come from a machine outside the body (external radiation therapy) or from putting materials that produce radiation (radioisotopes) through thin plastic tubes in the area where the cancer cells are found (internal radiation therapy).

If fluid has collected in the chest or abdomen, the doctor may drain the fluid out of the body by putting a needle into the chest or abdomen and using gentle suction to remove the fluid. If fluid is removed from the chest, this is called thoracentesis. If fluid is removed from the abdomen, this is called paracentesis. The doctor may also put drugs through a tube into the chest to prevent more fluid from accumulating.

Chemotherapy uses drugs to kill cancer cells. Chemotherapy may be taken by pill, or it may be put into the body by a needle in the vein or muscle. Chemotherapy is called a systemic treatment because the drug enters the bloodstream, travels through the body, and can kill cancer cells throughout the body. In mesothelioma, chemotherapy may be put directly into the chest (intrapleural chemotherapy).

Intraoperative photodynamic therapy is a new type of treatment that uses special drugs and light to kill cancer cells during surgery. A drug that makes cancer cells more sensitive to light is injected into a vein several days before surgery. During surgery to remove as much of the cancer as possible, a special light is used to shine on the pleura. This treatment is being studied for early stages of mesothelioma in the chest.

Recurrent Malignant Mesothelioma

Treatment depends on many factors, including where the cancer came back and what treatment the patient received before. Mesothelioma Clinical trials are testing new treatments.
READ MORE - Malignant Mesothelioma

Friday, 29 May 2009

Malignant mesothelioma risk increased after radiation treatment for HL

Patients with Hodgkin’s lymphoma who have been treated with radiation may be at an increased risk for malignant mesothelioma.

Although malignant mesothelioma is relatively uncommon, previous research indicated it may be associated with radiation exposure.

Results of several recent epidemiological studies showed that radiation for lymphoma may be linked with an increased risk for malignant mesothelioma. However, these studies involved only a small number of patients and the results needed to be confirmed in larger studies.

For this study, the researchers examined risk for malignant mesothelioma in 2,567 patients who had reached at least five-year survival after treatment for Hodgkin’s lymphoma.

Patients included in the study had been treated with radiation alone, chemotherapy alone or a combination of both.

Median follow-up period was 18.1 years. At this time, 13 patients had malignant mesothelioma at least five years after being treated for Hodgkin’s lymphoma.

Five-year survivors of Hodgkin’s lymphoma were about 26 times more likely than the general population to develop malignant mesothelioma, according to the results. Those treated with radiation alone were about 30 times more likely to develop malignant mesothelioma.

There were no cases of the disease among the 232 patients treated with chemotherapy alone, but patients treated with both radiation and chemotherapy were almost 44 times more likely to develop malignant mesothelioma.

READ MORE - Malignant mesothelioma risk increased after radiation treatment for HL

International Symposium on Malignant Mesothelioma coming to Town

The 2009 International Symposium on Malignant Mesothelioma has now been scheduled for the end of June. The event, which is organised by the Mesothelioma Applied Research Foundation (Meso Foundation) is set to be held in Washington DC from the 25th June until 27th June.

The event will be an interesting one that will involve raising awareness about asbestos related disease as well as looking at research and discussing the latest findings. A number of industry experts will be attending the event to provide details on various clinical trials, treatment, and research.

In addition to this many others will also be at the event, including sufferers of the asbestos related cancer, campaigners, advocates, and those that provide care for sufferers of mesothelioma. The event will take place at the Omni Shoreham Hotel, in Washington, DC.

Following the event the foundation will honor those that are living with the disease, and will also give out the three annual awards that it gives for political support, research contributions, and community support.

READ MORE - International Symposium on Malignant Mesothelioma coming to Town

Monday, 12 November 2007

Mesothelioma still needs more attention, research funding

Regarding the Oct. 15 front page article, ''Cancer death rates declining'': The death rate for mesothelioma, an extremely painful cancer in which membrane cells lining the chest or abdomen become malignant and proliferate uncontrollably, is on the rise.

Mesothelioma, caused by asbestos exposure, is almost always fatal. The life expectancy is 12.3 months with treatment and 9.2 months without. In fact, according to the National Center for Health Statistics, Pennsylvania ranks third in the nation in the mortality rate for mesothelioma.

Mesothelioma's latency is as long as 50 years, so millions of Americans who were exposed in the past five decades are at risk. And, given the current levels of asbestos exposure, it is inevitable that Americans will continue to be diagnosed for decades. The only hope is research to develop effective treatment.

Much has been accomplished with limited, private funding. It is time for the federal government to help find a cure. With facts like these, it is extremely distressing to know that less than 3 percent of cancer research dollars go to mesothelioma research. Wake up, Lehigh Valley; not all cancers or cancer death rates are on the decline.

SOURCE
READ MORE - Mesothelioma still needs more attention, research funding

LORDS' 'ILLNESS' RULING SLAMMED BY VICTIM

A retired dockyard worker who developed scars on his lungs after working with asbestos has attacked a House of Lords decision to end compensation for people with the condition.Ken Peach, aged 75, of Beacon Park, said the Law Lords ruling on pleural plaques - scars on the lungs usually caused by exposure to asbestos - is "disgusting".

The condition can lead to fatal diseases including malignant mesothelioma and other forms of lung cancer.

The House of Lords yesterday ruled that pleural plaques was not a disease, ending future claims.

The landmark decision could affect hundreds of people in Plymouth, which is a 'hotspot' for asbestos-related conditions.

SOURCE

Mr Peach joined unions, solicitors and Plymouth MP Linda Gilroy in criticism of the ruling.

The pensioner, who received a Government payout in 2001 after developing pleural plaques, said: "It's disgusting and I feel very sorry this decision was made.

"I have a five per cent chance of the scars on my lungs developing into something more serious. It's a horrible feeling to know it's there; it worries me."

Mr Peach joined Devonport Dockyard in 1952 when he was just 20, working as a joiner. His job involved fitting and ripping out layers of asbestos from submarines docked for routine maintenance.

Plymouth MP Linda Gilroy, who sits on the All-Party Parliamentary Group for Asbestos, said Plymouth has one of the country's highest rates of asbestos-realted conditions.

"This decision is a huge disappointment," she said.

"There will soon be a meeting of the all-party group and we will look at this issue, as well as many others surrounding asbestos-related conditions, and will endeavour to lend as much support to it as we can."

The latest figures show 320 people dying from mesothelioma caused by asbestos between 1985 and 2004.

Cases are expected to peak between 2011 and 2015, as the condition takes between 30 to 40 years to emerge.

John Messham, head of the occupational disease department at Bond Pearce in Plymouth, said the firm has seen around 200 successful cases for pleural plaques in the last five years - with pay outs of between £3,500 and £7,000.

He said: "I could say the House of Lords has failed to recognise the anxiety caused by pleural plaques.

"It's the right decision for insurers but not the many thousands of people across the country who have the condition, for who it will be a devastating blow."

He added around 30 Plymothians' cases would have to be dropped following the announcement.

Derek Simpson, joint general secretary of Unite, said: "This is a harsh decision which will affect thousands of people with pleural plaques now and in the future."

The only three UK areas with higher figures of asbestos-related diseases are Barrow-in-Furness, West Dumbartonshire and North Tyneside.
READ MORE - LORDS' 'ILLNESS' RULING SLAMMED BY VICTIM